NDC 0378-0464

MAXZIDE-25

Maxzide

MAXZIDE-25 is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Hydrochlorothiazide; Triamterene.

Product ID0378-0464_0e54ebec-df86-4205-9434-315913b56a94
NDC0378-0464
Product TypeHuman Prescription Drug
Proprietary NameMAXZIDE-25
Generic NameMaxzide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1988-05-13
Marketing End Date2024-03-31
Marketing CategoryNDA / NDA
Application NumberNDA019129
Labeler NameMylan Pharmaceuticals Inc.
Substance NameHYDROCHLOROTHIAZIDE; TRIAMTERENE
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesDecreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
NDC Exclude FlagN

Packaging

NDC 0378-0464-01

100 TABLET in 1 BOTTLE, PLASTIC (0378-0464-01)
Marketing Start Date1988-05-13
Marketing End Date2024-03-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0378-0464-01 [00378046401]

MAXZIDE-25 TABLET
Marketing CategoryNDA
Application NumberNDA019129
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1988-05-13

Drug Details

Active Ingredients

IngredientStrength
TRIAMTERENE37.5 mg/1

OpenFDA Data

SPL SET ID:e92eda49-861e-4c79-b446-ec1213151d92
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310812
  • 310818
  • 93252
  • 93253
  • UPC Code
  • 0303780376687
  • Pharmacological Class

    • Decreased Renal K+ Excretion [PE]
    • Increased Diuresis [PE]
    • Potassium-sparing Diuretic [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]
    • Decreased Renal K+ Excretion [PE]
    • Increased Diuresis [PE]
    • Potassium-sparing Diuretic [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "MAXZIDE-25" or generic name "Maxzide"

    NDCBrand NameGeneric Name
    0378-0464MAXZIDE-25maxzide
    0378-0460MAXZIDEmaxzide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.